Fabrizio De Carli

Fabrizio De Carli

Auto-generated profile, based on publicly available information

Fabrizio De Carli

Institute of Bioimaging and Molecular Physiology, Consiglio Nazionale delle Ricerche (CNR), Genoa, Italy

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2014 in Neurology
Verified
Journal Article
Closed access
PDF file
MPMarco Pagani
Marco Pagani
ACAdriano Chiò
Adriano Chiò
MVMaria Consuelo Valentini
Maria Consuelo Valentini
JÖJohanna Öberg
Johanna Öberg
FNFlavio Nobili
Flavio Nobili
ACAngelina Cistaro
Angelina Cistaro
Objective: We investigated a large sample of patients with amyotrophic lateral sclerosis (ALS) at rest in order to assess the value of 18F-2-fluoro-2-deoxy-d-glucose (18F-FDG) PET as a biomarker to discriminate patients from controls. Methods: A total of 195 patients with ALS and 40 controls underwent brain 18F-FDG-PET, most within 5 months of diagnosis. Spinal and bulbar subgroups of ALS were also investigated. Twenty-five bilateral cortical and subcortical volumes of interest and cerebellum were taken into account, and 18F-FDG uptakes were individually normalized by whole-brain values. Group analyses investigated the ALS-related metabolic changes. Discriminant analysis investigating sensitivity and specificity was performed using the 51 volumes of interest as well as age and sex. Metabolic connectivity was explored by voxel-wise interregional correlation analysis. Results: Hypometabolism was found in frontal, motor, and occipital cortex and hypermetabolism in midbrain, temporal pole, and hippocampus in patients with ALS compared to controls. A similar metabolic pattern was also found in the 2 subgroups. Discriminant analysis showed a sensitivity of 95% and a specificity of 83% in separating patients from controls. Connectivity analysis found a highly significant positive correlation between midbrain and white matter in corticospinal tracts in patients with ALS. Conclusions: 18F-FDG distribution changes in ALS showed a clear pattern of hypometabolism in frontal and occipital cortex and hypermetabolism in midbrain. The latter might be interpreted as the neurobiological correlate of diffuse subcortical gliosis. Discriminant analysis resulted in high sensitivity and specificity in differentiating patients with ALS from controls. Once validated by diseased-control studies, the present methodology might represent a potentially useful biomarker for ALS diagnosis. Classificaton of evidence: This study provides Class III evidence that 18F-FDG-PET accurately distinguishes patients with ALS from normal controls (sensitivity 95.4%, specificity 82.5%).

1 September 2011 in NeuroImage
Verified
Journal Article
Closed access
LNLino Nobili
Lino Nobili
Michele FerraraMichele Ferrara
Michele Ferrara
FMFabio Moroni
Fabio Moroni
Luigi De GennaroLuigi De Gennaro
Luigi De Gennaro
GRGiorgio Lo Russo
Giorgio Lo Russo
FCFabrizio De Carli
Fabrizio De Carli

1 March 2001 in SLEEP
Verified
Journal Article
Open access
PDF file
Sergio GarbarinoSergio Garbarino
Sergio Garbarino
LNLino Nobili
Lino Nobili
MBManolo Beelke
Manolo Beelke
FCFabrizio De Carli
Fabrizio De Carli
FFFranco Ferrillo
Franco Ferrillo
To evaluate the contributing role of sleepiness in Italian highway vehicle accidents during the time span 1993–1997. We analyzed separately the hourly distribution of accidents ascribed by police officers univocally to sleepiness and the rest. N/A N/A Using a polynomial regression, we evaluated the relation between accidents (whether sleep-ascribed or not) and sleepiness as derived from a 24-hour sleep propensity curve. The relation between sleep-influenced and non-sleep influenced accidents was analysed using a linear regression The rate of non-sleep ascribed accidents is closely related with sleep propensity and bears a strong similarity with the pattern of sleep-ascribed accidents. A close relationship between the curves of non-sleep ascribed accidents and sleep-ascribed accidents is confirmed. The regression coefficient, which can be seen as the ratio between the quota of accidents that can be considered as sleep affected and those actually ascribed to sleepiness, results in a value of 5.83. Considering that the rate of sleep ascribed accidents is 3.2%, we can calculate the quota of sleep influenced accidents out of those not officially ascribed to sleepiness as 18.7% reaching an estimate of accidents related in some way to sleepiness equal to 21.9%. Our indirect estimate of sleep influenced accidents approaches data reported by other European countries and highlights the importance of sleepiness as a direct and/or contributing factor in vehicle accident rates.

1 January 2012
Verified
Book Chapter
Closed access
LNLino Nobili
Lino Nobili
Luigi De GennaroLuigi De Gennaro
Luigi De Gennaro
PPPaola Proserpio
Paola Proserpio
FMFabio Moroni
Fabio Moroni
SSSimone Sarasso
Simone Sarasso
Michele FerraraMichele Ferrara
Michele Ferrara

29 June 2017 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
MPMarco Pagani
Marco Pagani
FNFlavio Nobili
Flavio Nobili
Silvia MorbelliSilvia Morbelli
Silvia Morbelli
Dario ArnaldiDario Arnaldi
Dario Arnaldi
Alessandro GiulianiAlessandro Giuliani
Alessandro Giuliani
FCFabrizio De Carli
Fabrizio De Carli

1 August 1993 in Stroke
Verified
Journal Article
Closed access
FNFlavio Nobili
Flavio Nobili
GRG Rodriguez
G Rodriguez
SMS Marenco
S Marenco
FCF De Carli
F De Carli
MGM Gambaro
M Gambaro
GRG Rosadini
G Rosadini
Cerebral hypoperfusion has occasionally been reported during essential hypertension. We explored regional cerebral blood flow in a large series of neurologically asymptomatic hypertensive patients to determine relations among cerebral blood flow, concomitant main vascular risk factors, and the most common signs of end-organ damage. Regional cerebral blood flow was measured by the 133Xe inhalation method in 101 hypertensive patients without clinically apparent central nervous system involvement, including 39 mild to moderate untreated and 62 mild to severe treated patients. Compared with age- and sex-matched normal control subjects, cerebral blood flow was significantly reduced in untreated hypertensive patients (P < .01) and to a lesser extent in treated patients (P = .047). Both regional and global cerebral blood flow reductions were observed in approximately one third of patients in both groups. Analysis of variance failed to show significant correlations between cerebral blood flow and total cholesterol concentration, mean arterial blood pressure, duration of disease, or the presence of retinopathy or left ventricular hypertrophy. In the treated group, the quality of control of hypertension significantly influenced both global cerebral blood flow (P = .007) and cerebrovascular resistance (P < .0001). Focal or diffuse cerebral hypoperfusion is present even in neurologically asymptomatic hypertensive patients, especially when untreated; good control of blood pressure may preserve cerebral perfusion and reduce cerebrovascular resistance. Regional cerebral blood flow examination represents a relatively simple and low-cost technique to explore the perfusional condition of the brain, one of the main target organs of hypertensive disease.